These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34854250)
1. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA. Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250 [TBL] [Abstract][Full Text] [Related]
2. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma. Dong M; Yang Z; Li X; Zhang Z; Yin A Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775 [TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients. Shi S; Xu M; Xi Y Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038 [TBL] [Abstract][Full Text] [Related]
4. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma. Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158 [TBL] [Abstract][Full Text] [Related]
5. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method. Cai Q; He B; Xie H; Zhang P; Peng X; Zhang Y; Zhao Z; Wang X Cancer Med; 2020 Oct; 9(20):7488-7502. PubMed ID: 32860318 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis. Pan X; Ji P; Deng X; Chen L; Wang W; Li Z Gene; 2022 Feb; 810():146054. PubMed ID: 34737001 [TBL] [Abstract][Full Text] [Related]
8. Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome. Maki M; JeongMin H; Nakagawa T; Kawai H; Sakamoto N; Sato Y; Noguchi M Pathol Int; 2022 Oct; 72(10):496-505. PubMed ID: 35920378 [TBL] [Abstract][Full Text] [Related]
9. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma. Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575 [TBL] [Abstract][Full Text] [Related]
10. Zhang W; Li T; Hu B; Li H Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541 [TBL] [Abstract][Full Text] [Related]
11. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989 [TBL] [Abstract][Full Text] [Related]
12. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma. He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
14. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma. Wang H; Wei C; Pan P; Yuan F; Cheng J Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305 [TBL] [Abstract][Full Text] [Related]
15. Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma. Shu M; Huang L; Chen Y; Wang Y; Xie Z; Li S; Zhou J; Wei L; Fu T; Liu B; Chen H; Tang K; Ke Z Cancer Lett; 2024 Jul; 593():216835. PubMed ID: 38548216 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma. Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma. Tian W; Li YS; Zhang JH; Li JJ; Gao JH DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer. Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760 [TBL] [Abstract][Full Text] [Related]
20. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma. Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]